Literature DB >> 22399430

Mitochondria and drugs.

Roberto Scatena1.   

Abstract

Mitochondria play a central role in the life and death of cells. They are not merely the centre for energy metabolism, but are also the headquarters for different catabolic and anabolic processes, calcium fluxes, and various signalling pathways. Mitochondria maintain homeostasis in the cell by interacting with reactive oxygen-nitrogen species and responding adequately to different stimuli. In this context, the interaction of pharmacological agents with mitochondria is an aspect of molecular biology that is too often disregarded, not only in terms of toxicology but also from a therapeutic point of view, especially considering the potential therapeutic applications related to the modulation of mitochondrial activity.At the mitochondrial level, there are several potential drug targets that can lead to toxicity, but only for few of them, a real clinical counterpart has been demonstrated. Recently, antiviral nucleoside analogues have shown mitochondrial toxicity through the inhibition of DNA polymerase-gamma. Other drugs targeted to different components of the mitochondrial channels can disrupt ion homeostasis or affect the mitochondrial permeability transition pore. Many molecules are known inhibitors of the mitochondrial electron transport chain, interfering with one or more of the complexes in the respiratory chain. Some drugs, including non-steroidal anti-inflammatory drugs (NSAIDs), may lead to uncoupling of oxidative phosphorylation, while the mitochondrial toxicity of other drugs seems to depend on the production of free radicals, although this mechanism has yet to be defined. Besides toxicity, other drugs have been targeted to mitochondria to treat mitochondrial dysfunctions. Many drugs have been recently developed to target the mitochondria of cancer cells in order to trigger apoptosis or necrosis. The aim of this chapter is to underline the role of mitochondria in pharmacology and toxicology, stressing all the potential therapeutic approaches being due to iatrogenic modulation of the multitude of mitochondrial activities.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22399430     DOI: 10.1007/978-94-007-2869-1_15

Source DB:  PubMed          Journal:  Adv Exp Med Biol        ISSN: 0065-2598            Impact factor:   2.622


  9 in total

1.  The anti-tumor effect and biological activities of the extract JMM6 from the stem-barks of the Chinese Juglans mandshurica Maxim on human hepatoma cell line BEL-7402.

Authors:  Yongli Zhang; Yuqiang Cui; Jiayong Zhu; Hongzhi Li; Jianwen Mao; Xiaobao Jin; Xiangsheng Wang; Yifan Du; Jiazheng Lu
Journal:  Afr J Tradit Complement Altern Med       Date:  2012-12-31

2.  Electron Attachment to Isolated Molecules as a Probe to Understand Mitochondrial Reductive Processes.

Authors:  Stanislav A Pshenichnyuk; Alberto Modelli
Journal:  Methods Mol Biol       Date:  2021

3.  Senescent Phenotype Induced by p90RSK-NRF2 Signaling Sensitizes Monocytes and Macrophages to Oxidative Stress in HIV-Positive Individuals.

Authors:  Meera V Singh; Sivareddy Kotla; Nhat-Tu Le; Kyung Ae Ko; Kyung-Sun Heo; Yin Wang; Yuka Fujii; Hang Thi Vu; Elena McBeath; Tamlyn N Thomas; Young Jin Gi; Yunting Tao; Jan L Medina; Jack Taunton; Nancy Carson; Vikram Dogra; Marvin M Doyley; Alicia Tyrell; Wang Lu; Xing Qiu; Nicole E Stirpe; Kathleen J Gates; Christine Hurley; Keigi Fujiwara; Sanjay B Maggirwar; Giovanni Schifitto; Jun-Ichi Abe
Journal:  Circulation       Date:  2019-02-26       Impact factor: 29.690

4.  Hypoxia-inducible factor 1-α induces miR-210 in normoxic differentiating myoblasts.

Authors:  Lucia Cicchillitti; Valeria Di Stefano; Eleonora Isaia; Luca Crimaldi; Pasquale Fasanaro; Valeria Ambrosino; Annalisa Antonini; Maurizio C Capogrossi; Carlo Gaetano; Giulia Piaggio; Fabio Martelli
Journal:  J Biol Chem       Date:  2012-11-12       Impact factor: 5.157

5.  Nonclinical and pharmacokinetic assessments to evaluate the potential of tedizolid and linezolid to affect mitochondrial function.

Authors:  Shawn Flanagan; Edward E McKee; Debaditya Das; Paul M Tulkens; Hiromi Hosako; Jill Fiedler-Kelly; Julie Passarell; Ann Radovsky; Philippe Prokocimer
Journal:  Antimicrob Agents Chemother       Date:  2014-10-20       Impact factor: 5.191

6.  Protein Kinase A/CREB Signaling Prevents Adriamycin-Induced Podocyte Apoptosis via Upregulation of Mitochondrial Respiratory Chain Complexes.

Authors:  Kewei Xie; Mingli Zhu; Peng Xiang; Xiaohuan Chen; Ayijiaken Kasimumali; Renhua Lu; Qin Wang; Shan Mou; Zhaohui Ni; Leyi Gu; Huihua Pang
Journal:  Mol Cell Biol       Date:  2017-12-13       Impact factor: 4.272

7.  Mitochondrial Respiratory Complexes as Targets of Drugs: The PPAR Agonist Example.

Authors:  Patrizia Bottoni; Alessandro Pontoglio; Salvatore Scarà; Luisa Pieroni; Andrea Urbani; Roberto Scatena
Journal:  Cells       Date:  2022-03-30       Impact factor: 6.600

Review 8.  An Epigenetic Role of Mitochondria in Cancer.

Authors:  Yu'e Liu; Chao Chen; Xinye Wang; Yihong Sun; Jin Zhang; Juxiang Chen; Yufeng Shi
Journal:  Cells       Date:  2022-08-13       Impact factor: 7.666

Review 9.  Calcium Permeable Channels in Cancer Hallmarks.

Authors:  Sendoa Tajada; Carlos Villalobos
Journal:  Front Pharmacol       Date:  2020-07-07       Impact factor: 5.810

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.